Shaban Ahmad

1.5k total citations
48 papers, 798 citations indexed

About

Shaban Ahmad is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Shaban Ahmad has authored 48 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Computational Theory and Mathematics and 11 papers in Organic Chemistry. Recurrent topics in Shaban Ahmad's work include Computational Drug Discovery Methods (18 papers), Synthesis and biological activity (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Shaban Ahmad is often cited by papers focused on Computational Drug Discovery Methods (18 papers), Synthesis and biological activity (10 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Shaban Ahmad collaborates with scholars based in India, Saudi Arabia and China. Shaban Ahmad's co-authors include Khalid Raza, Manoj Kumar Yadav, Hemant K. Gautam, Mutaib M. Mashraqi, Ahmad Alzamami, Norah A. Alturki, Saleh Alshamrani, Youssef Saeed Alghamdi, Vijay Singh and Sahar Qazi and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Shaban Ahmad

44 papers receiving 790 citations

Peers

Shaban Ahmad
Clement Agoni South Africa
Gabriela Bitencourt‐Ferreira Brazil
Panupong Mahalapbutr Thailand
Sayaka Mizutani Japan
Gautier Moroy France
Shama Khan South Africa
Shailima Rampogu South Korea
Prem Prakash Kushwaha India
Fisayo A. Olotu South Africa
Maha M. Abdel‐Fattah Egypt
Clement Agoni South Africa
Shaban Ahmad
Citations per year, relative to Shaban Ahmad Shaban Ahmad (= 1×) peers Clement Agoni

Countries citing papers authored by Shaban Ahmad

Since Specialization
Citations

This map shows the geographic impact of Shaban Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaban Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaban Ahmad more than expected).

Fields of papers citing papers by Shaban Ahmad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaban Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaban Ahmad. The network helps show where Shaban Ahmad may publish in the future.

Co-authorship network of co-authors of Shaban Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Shaban Ahmad. A scholar is included among the top collaborators of Shaban Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaban Ahmad. Shaban Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahmad, Shaban, et al.. (2025). FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. Computers in Biology and Medicine. 191. 110163–110163. 2 indexed citations
3.
Ahmad, Shaban, et al.. (2025). Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics. Journal of drug targeting. 33(10). 1807–1826.
4.
5.
Ahmad, Shaban, et al.. (2024). Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis. International Journal of Biological Macromolecules. 270(Pt 2). 132332–132332. 14 indexed citations
6.
7.
Ahmad, Shaban & Khalid Raza. (2024). An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives. Journal of drug targeting. 32(6). 635–646. 21 indexed citations
8.
Ahmad, Shaban, et al.. (2024). Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies. International Journal of Biological Macromolecules. 276(Pt 1). 133872–133872. 17 indexed citations
9.
Rana, Manish, Aysha Fatima, Shaban Ahmad, et al.. (2023). Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog. Journal of Molecular Structure. 1287. 135701–135701. 21 indexed citations
10.
Sahu, Ankita, Shaban Ahmad, Khalid Imtiyaz, et al.. (2023). In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma. Scientific Reports. 13(1). 16545–16545. 16 indexed citations
11.
12.
Zlatkov, Alexander, et al.. (2023). Structure-Based Design of Novel MAO-B Inhibitors: A Review. Molecules. 28(12). 4814–4814. 21 indexed citations
13.
Ahmad, Shaban, et al.. (2022). Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study. Journal of Biomolecular Structure and Dynamics. 41(9). 4013–4023. 39 indexed citations
14.
Yadav, Manoj Kumar, et al.. (2022). Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 41(5). 1527–1539. 52 indexed citations
15.
Qazi, Sahar, et al.. (2022). Antiviral Potential of Indian Medicinal Plants Against Influenza and SARS-CoV: A Systematic Review. Natural Product Communications. 17(3). 12 indexed citations
16.
Alturki, Norah A., Mutaib M. Mashraqi, Ahmad Alzamami, et al.. (2022). In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2. Molecules. 27(14). 4391–4391. 54 indexed citations
17.
Alzamami, Ahmad, Norah A. Alturki, Youssef Saeed Alghamdi, et al.. (2022). Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study. Medicina. 58(4). 515–515. 30 indexed citations
18.
Ahmad, Shaban. (2022). Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid. Bioinformation. 18(3). 170–179. 35 indexed citations
19.
Kaul, Tanushri, et al.. (2019). Probing the effect of a plus 1bp frameshift mutation in protein-DNA interface of domestication gene, NAMB1, in wheat. Journal of Biomolecular Structure and Dynamics. 38(12). 3633–3647. 20 indexed citations
20.
Ahmad, Shaban, et al.. (2017). A switching based PID technique for blood glucose control. Biomedical Research-tokyo. 28(19). 8477–8483. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clement Agoni Breakdown of academic impact, for papers by Gabriela Bitencourt‐Ferreira Breakdown of academic impact, for papers by Panupong Mahalapbutr Breakdown of academic impact, for papers by Sayaka Mizutani Breakdown of academic impact, for papers by Gautier Moroy Breakdown of academic impact, for papers by Shama Khan Breakdown of academic impact, for papers by Shailima Rampogu Breakdown of academic impact, for papers by Prem Prakash Kushwaha Breakdown of academic impact, for papers by Fisayo A. Olotu Breakdown of academic impact, for papers by Maha M. Abdel‐Fattah
Rankless by CCL
2026